In summary, BDNF and its equivalent drugs may be a promising therapeutic strategy for ALS, but further researches are needed to overcome the difficulties of poor pharmacokinetics and pharmacodynamics of BDNF. Here, BDNF is linked to amyotrophic lateral sclerosis.